ACTIVE SUBSTANCE / INN

VIBEGRON

Brand name(s): GEMTESA, Obgemsa
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Urinary Bladder, Overactive;Urinary Incontinence
NDA213006
ACTIVE SUBSTANCE
Vibegron
REGULATORS
FDA · EMA
SPONSORS / MAH
Pierre Fabre Medicament, SUMITOMO PHARMA AM
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
GEMTESANDA213006SUMITOMO PHARMA AMPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ObgemsaPierre Fabre MedicamentAuthorised27/06/2024Urinary Bladder, Overactive;Urinary Incontinence

FULL INTELLIGENCE ON VIBEGRON

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →